ACTH release in pituitary cell cultures. Effect of neurogenic peptides and neurotransmitter substances on ACTH release induced by hypothalamic corticotropin releasing factor (CRF).

DOI Web Site Web Site PubMed
  • HASHIMOTO Kozo
    Third Department of Internal Medicine, Okayama University Medical School
  • YUNOKI SHO
    Third Department of Internal Medicine, Okayama University Medical School
  • TAKAHARA JIRO
    Third Department of Internal Medicine, Okayama University Medical School
  • OFUJI TADASHI
    Third Department of Internal Medicine, Okayama University Medical School

書誌事項

タイトル別名
  • ACTH Release in Pituitary Cell Cultures

この論文をさがす

抄録

The effects of various neurogenic peptides and neurotransmitter substances on the release of ACTH induced by hypothalamic corticotropin releasing factor (HYCRF) were investigated using monolayer cultured anterior pituitary cells. Test substances were given in combination with 0.05-0.1 hypothalamic extract (HE)/ml, because HE evoked a significant ACTH release and a linear dose response relationship was demonstrated sequentially between 0, 0165 HE/ml and 0.5HE/ml. Relatively high doses of lysine-vasopressin showed a slight additive effect onl the release of ACTH induced by 0.1HE/ml. Leu-enkephalin, dopamine, prostaglandin E1 and E2 slightly reduced the release of ACTH induced by HY-CRF, but the inhibitory effect of these substances were not dose-related. Other tested substances including luteinizing hormone releasing hormone, thyrottopin releasing hormone, somatostatin, melanocyte stimulating hormone release inhibiting factor, β-endorphin, neurotensin, substance P, vasoactive intestinal polypeptide, angiotensin II, norepinephrine, serotonin, acetylcholine, histamine and γ-amino butyric acid showed neither agonistic nor antagonistic effect on the release of ACTH induced by HY-CRF. These results indicate that the release of ACTH is controlled specifically by HY-CRF and corticosterone, and modified slightly by some other substances such as vasopressin and prostaglandins, and that the effect of most other neurogenic peptides and neurotransmitter substances is negligible or non-physiological at the pituitary level.

収録刊行物

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ